FacebookTwitterGoogle+RedditEmail

After Billions Are Made, Risks from Asthma Drug Emerge

by MARTHA ROSENBERG

World sales of Merck’s blockbuster asthma drug, Singulair, were about $5 billion a year until last year when its patent expired in the United States. But the drug also has a darkening cloud over it. The Australian medicine watchdog has received 58 reports of adverse psychiatric events in children and teenagers taking Singulair since 2000 and reports have also surfaced in the US.

Singulair, a leukotriene receptor antagonist or LTRA, is one of several “add-on” asthma drugs that were debuted in the last decade. Patients are supposed to add the new, “asthma controller” drugs to their regular rescue inhalers and inhaled corticosteroids not replace them. Ka-ching.

In the US, Singulair was heavily marketed for minor childhood allergies, in addition to asthma, and sold in a cherry-flavored chewable formulation. Merck had marketing partnerships with Scholastic, a leading educational publishing group, and the American Academy of Pediatrics, reported the US’ Fox News.

Sales pieces from the Scholastic/ Merck partnership cajoled parents, “When your child breathes in an asthma trigger, such as pollen from trees or weeds, the body releases leukotrienes (loo-ko-TRY-eens)” which Singulair blocks. But they also told parents their children could experience, “hallucinations (seeing things that are not there), irritability, restlessness, sleepwalking, suicidal thoughts and actions (including suicide), trembling, and trouble sleeping,” on the drug. At least they wouldn’t be sniffling.

In 2009, after 15-year-old Cody Miller of Queensbury, NY was given Singulair for hay fever and took his own life 17 days later, the US Food and Drug Administration (FDA) gave Singulair a stronger warning for “neuropsychiatric” side effects. The next year, Fox TV, a leading US television network, reported that children on Singulair are being diagnosed with ADHD, Tourette Syndrome and serious behavioral and neurological conditions caused by the drugs. Most are “cured” when they go off the drug but some are not and are then given other damaging pediatric behavioral drugs.

Over 100 parents on the popular US drug-rating web site askapatient.com, corroborate the evidence, reporting that Singulair caused hyperactivity, tantrums, depression, crying, school trouble, facial tics, strange eye movements and self-harm in their children, some as young as one year old. Many of the children were prescribed Singulair for sniffles and wheezing which were called early symptoms of asthma, commensurate with Pharma’s “early treatment” business model.

“Last night was a complete meltdown over every single thing that could have possibly been a minor annoyance, such as not being able to squeeze enough toothpaste out of the tube, which culminated in a 30-minute screaming and crying bonanza,” writes the mother of a 7-year-old who has been on Singulair for six months. “I was reading stories to her tonight, and she must have popped her jaw open at least 40 times over the course of two books (mouth open wide like a yawn in fast-forward). I was keeping an eye on her, and a few times I asked her why she kept doing that and she said she didn’t know, and she thought maybe her mouth was ‘itchy.'”

“Do NOT recommend this drug to other parents,” writes another mother. “4 year olds that suddenly talk about killing themselves are influenced by a DRUG!!”

Even adults are put on Singulair for minor reasons with major consequences. “I was perfectly healthy prior to taking this drug,” reports a 53-year-old woman about Singulair on the askapatient web site.  “Doc noticed I had a little wheeze and prescribed Singulair. I began to have the dreams, insomnia and depression after the first few days,” which led to “suicidal thoughts,” she says.

Like many of Big Pharma’s blockbuster drugs, Singulair made billions by selling “diseases”–in this case childhood allergies and asthma. And like many blockbuster drugs, the true dangers have only emerged since the drug went off patent and the profit potential was gone.

Watch Martha on a Huffington Live discussing the pharmaceutical industry.

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

More articles by:

Martha Rosenberg is an investigative health reporter. She is the author of  Born With A Junk Food Deficiency: How Flaks, Quacks and Hacks Pimp The Public Health (Prometheus).

CounterPunch Magazine

minimag-edit

bernie-the-sandernistas-cover-344x550

zen economics

Weekend Edition
July 28, 2017
Friday - Sunday
Joseph Natoli
Choosing the ‘Arteries that Make Money’
CJ Hopkins
Intersectionalist Internet Blues
Pepe Escobar
China and India Torn Between Silk Roads and Cocked Guns
Ralph Nader
Can the World Defend Itself From Omnicide?
Howard Lisnoff
Agape While Waltzing at the Precipice
Musa Al-Gharbi
Want to Shake Up Status Quo? Account for the Default Effect
Angela Kim
North Korean Policy Must Focus on Engagement Not Coercion
David Macaray
Talking Union
Binoy Kampmark
Refugee Conundrums: Resettlement, the UN and the US-Australia Deal
Robert Koehler
Opening Gitmo to the World
David Jaffee
No Safe Space for Student X
Thomas Knapp
The State is at War — With the Future
David Swanson
What’s Missing from Dunkirk Film
Winslow Myers
There Is Still Time, Brother
Robert J. Burrowes
Biological Annihilation on Earth Accelerating
Frederick B. Hudson – Dr. Junis Warren
Robot Scientists Carry Heavy Human Hearts 
CP Editor
Not My Brother’s Reefer
Sam Lichtman
Where are the Millennials?
Louis Proyect
Death Race: the Cruelties of the Iditarod
Charles R. Larson
Review: Norman Lock’s A Fugitive in Walden Woods
July 27, 2017
Edward Curtin
The Deep State, Now and Then
Melvin Goodman
The Myth of American Exceptionalism
Nozomi Hayase
From Watergate to Russiagate: the Hidden Scandal of American Power
Kenneth Surin
Come Fly the Unfriendly Skies
Andre Vltchek
Philippines: Western Media is Distorting Reality, People and Army Unite to Battle “ISIS”
Robert Fisk
Out of the Ruins of Aleppo: a Syrian Community Begins to Rebuild
Andrew Moss
What is Adelanto?
Thomas Mountain
Free Speech or Terror TV? Al Jazeera’s Support for ISIS and Al Queda
Robert J. - Byers
Jamboree Travesty
Thomas Knapp
Send in the Clown: Scaramucci Versus the Leakers
Rob Seimetz
Because the Night Belonged to Us in St. Petersburg (Florida)
Paul Cantor
Momentum Not Mojo
Patrick Walker
In Defense of Caitlin Johnstone (Part Two)
July 26, 2017
John W. Whitehead
Policing for Profit: Jeff Sessions & Co.’s Thinly Veiled Plot to Rob Us Blind
Pete Dolack
Trump’s Re-Negotiation Proposal Will Make NAFTA Worse
George Capaccio
“Beauty of Our Weapons” in the War on Yemen
Ramzy Baroud
Fear and Trepidation in Tel Aviv: Is Israel Losing the Syrian War?
John McMurtry
Brexit Counter-Revolution Still in Motion
Ted Rall
The Democrats Are A Lost Cause
Tom Gill
Is Macron Already Faltering?
Ed Kemmick
Empty Charges Erode Trust in Montana Elections
Rev. William Alberts
Fake News? Or Fake Faith?
James Heddle
The Ethics and Politics of Nuclear Waste are Being Tested in Southern California
Binoy Kampmark
Slaying in Minneapolis: Justine Damond, Shooting Cultures and Race
Jeff Berg
Jonesing for Real Change
FacebookTwitterGoogle+RedditEmail